AAPG
AscentageยทNASDAQ
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --
Key Stats
0.0000DAY`S RANGE0.0000
0.000052 WK RANGE0.0000
0.0000
0.0000
--
--
--
--
--
--
--
--
--
--
--
--
--
--
0.0000
0.0000
0.0000
0.0000
About AAPG
Ascentage Pharma Group International
A Chinese based and globally oriented original new drug research and development enterprise
Pharmaceutical
11/17/2017
01/24/2025
NASDAQ Stock Exchange
605
12-31
Depository Receipts (Ordinary Shares)
68 Xinqing Road, Suzhou Industrial Park, Suzhou, Jiangsu, China
The company is a global integrated biopharmaceutical company engaged in the discovery, development and commercialization of first-of-its-kind and best-in-class therapies to address the global unmet medical needs of hematological malignancies.
Ascentage Pharmaceutical Group is a holding company mainly engaged in the discovery, research and development and commercialization of drugs for the treatment of hematological malignancies. The company's main business is the development and sale of new small-scale therapies for cancer, hepatitis B and aging-related diseases. The company's main products include Olverembatinib (HQP1351), Lisaftoclax (APG-2575), Alrizomadlin (APG-115), Pelcitoclax (APG-1252), APG-5918 and other products. The company's products are primarily used to treat major hematological malignancies, including chronic myeloid leukemia, acute myeloid leukemia, chronic lymphocytic leukemia, acute lymphoblastic leukemia, myelodysplastic syndrome and multiple myeloma. The company mainly operates in the domestic market.
Company Financials
Forecast
Wall Street Opinions
Price Target
Volume Profile
Trade Flow Insight
Seasonals
Community Forum
Loading...
Related News
No articles available
